Literature DB >> 27879989

CD274 (PD-L1)/PDCD1 (PD-1) expression in de novo and transformed diffuse large B-cell lymphoma.

Anna Kwiecinska1, Nikolaos Tsesmetzis1, Mehran Ghaderi1, Lorand Kis1, Leonie Saft1, George Z Rassidakis1.   

Abstract

Entities:  

Keywords:  Non-Hodgkin lymphoma; PDCD1 (PD-1); immunotherapy; macrophages, CD274 (PD-L1)

Mesh：

Substances：

Year:  2016        PMID： 27879989     DOI： 10.1111/bjh.14432

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  High tumoral PD-L1 expression and low PD-1+ or CD8+ tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system.

Authors:  Sehui Kim; Soo Jeong Nam; Changhee Park; Dohee Kwon; Jeemin Yim; Seung Geun Song; Chan-Young Ock; Young A Kim; Sung Hye Park; Tae Min Kim; Yoon Kyung Jeon
Journal:  Oncoimmunology       Date:  2019-06-10       Impact factor: 8.110

2.  PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma.

Authors:  V Atsaves; N Tsesmetzis; D Chioureas; L Kis; V Leventaki; E Drakos; T Panaretakis; D Grander; L J Medeiros; K H Young; G Z Rassidakis
Journal:  Leukemia       Date:  2017-03-27       Impact factor: 11.528

Review 3.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

Review 4.  Immune Dysfunction in Non-Hodgkin Lymphoma: Avenues for New Immunotherapy-Based Strategies.

Authors:  Lorenzo Falchi
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

5.  Using Machine Learning Modeling to Explore New Immune-Related Prognostic Markers in Non-Small Cell Lung Cancer.

Authors:  Jiasheng Xu; Han Nie; Jiarui He; Xinlu Wang; Kaili Liao; Luxia Tu; Zhenfang Xiong
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244

6.  CD163+CD204+ tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma.

Authors:  Keigo Kubota; Masafumi Moriyama; Sachiko Furukawa; Haque A S M Rafiul; Yasuyuki Maruse; Teppei Jinno; Akihiko Tanaka; Miho Ohta; Noriko Ishiguro; Masaaki Yamauchi; Mizuki Sakamoto; Takashi Maehara; Jun-Nosuke Hayashida; Shintaro Kawano; Tamotsu Kiyoshima; Seiji Nakamura
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

7.  [Study on enhancing the killing activity of chemotherapy drugs by PD-1 inhibitor on Raji cell line].

Authors:  R Zhang; X Li; Z Li; Y Y Jiang; L Ma; M F Zhao; Q Deng
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

8.  Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma.

Authors:  Emilio Bellitti; Pierluigi Masciopinto; Pellegrino Musto; Elena Arcuti; Luca Mastracci; Giuseppina Opinto; Sabino Ciavarella; Attilio Guarini; Gerardo Cazzato; Giorgina Specchia; Eugenio Maiorano; Francesco Gaudio; Giuseppe Ingravallo
Journal:  Curr Oncol       Date:  2022-08-25       Impact factor: 3.109

Review 9.  PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.

Authors:  Zijun Y Xu-Monette; Jianfeng Zhou; Ken H Young
Journal:  Blood       Date:  2017-11-08       Impact factor: 25.476

Review 10.  Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma.

Authors:  Jun Zhang; L Jeffrey Medeiros; Ken H Young
Journal:  Front Oncol       Date:  2018-09-10       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.